In The News
BHP, Rio Tinto harassment class action members might number thousands, court told
Slater & Gordon refers former employee to police over email with salary data
Non-compete clauses to get ax for employees earning under $175,000
Ex-Spotlight producer Taylor Auerbach sues Seven over Lehrmann comments
PwC settles former tax partner’s case over retirement payments
Lawyer accused of attempted blackmail wins round against Canberra firm
Chief of staff to Deputy PM Richard Marles drops bullying case
Beckman Coulter shoots down biotech’s stem cell trade mark
‘Egregious failure’ by lender’s counsel in appeal against ASIC win: court
CIMIC class action funder asks court to rule on hypothetical commission
Please login to bookmark Close

Pharmacor will be allowed to sell a generic version of heart drug Entresto after the Full Court rejected Swiss drug giant Novartis’ appeal of a ruling that found an extension of the term of its patent for the drug was invalidly granted.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au